Acumen Pharmaceuticals Statistics Share Statistics Acumen Pharmaceuticals has 60.57M
shares outstanding. The number of shares has increased by 0.82%
in one year.
Shares Outstanding 60.57M Shares Change (YoY) 0.82% Shares Change (QoQ) 0.82% Owned by Institutions (%) 66.48% Shares Floating 46.91M Failed to Deliver (FTD) Shares 395 FTD / Avg. Volume 0.09%
Short Selling Information The latest short interest is 1.51M, so 2.49% of the outstanding
shares have been sold short.
Short Interest 1.51M Short % of Shares Out 2.49% Short % of Float 3.35% Short Ratio (days to cover) 2.16
Valuation Ratios The PE ratio is -1.01 and the forward
PE ratio is -0.82.
Acumen Pharmaceuticals's PEG ratio is
-0.02.
PE Ratio -1.01 Forward PE -0.82 PS Ratio 0 Forward PS n/a PB Ratio 0.57 P/FCF Ratio -1.2 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Acumen Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.46,
with a Debt / Equity ratio of 0.16.
Current Ratio 6.46 Quick Ratio 6.46 Debt / Equity 0.16 Debt / EBITDA -0.3 Debt / FCF -0.34 Interest Coverage -28.03
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.68M Employee Count 61 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -44.92% in the
last 52 weeks. The beta is 0.14, so Acumen Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.14 52-Week Price Change -44.92% 50-Day Moving Average 1.28 200-Day Moving Average 1.56 Relative Strength Index (RSI) 48.58 Average Volume (20 Days) 454,556
Income Statement
Revenue n/a Gross Profit n/a Operating Income -114.02M Net Income -102.33M EBITDA -98.08M EBIT -98.26M Earnings Per Share (EPS) -1.71
Full Income Statement Balance Sheet The company has 35.63M in cash and 29.7M in
debt, giving a net cash position of 5.92M.
Cash & Cash Equivalents 35.63M Total Debt 29.7M Net Cash 5.92M Retained Earnings -325.13M Total Assets 204.48M Working Capital 135.63M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -86.22M
and capital expenditures -16K, giving a free cash flow of -86.23M.
Operating Cash Flow -86.22M Capital Expenditures -16K Free Cash Flow -86.23M FCF Per Share -1.44
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
